TP53 and breast carcinoma: Moreover, the level of CA15-3 was significantly higher in breast cancer patients compared to healthy-matched controls based on our data, and this high level positively correlated with patients’ ages and tumor sizes, as well as the presence of p53 and lymph and vascular invasion.